The ABC of non-inferiority margin setting from indirect comparisons.
- Published in:
- Pharmaceutical Statistics, 2011, v. 10, n. 5, p. 448, doi. 10.1002/pst.517
- By:
- Publication type:
- Article
Works matching IS 15391604 AND DT 2011 AND VI 10 AND IP 5
Results: 16
1
2
DNA methylation microarrays: Experimental design and statistical analysis, Sun-Chong Wang, Arturas Petronis (2008) ISBN: 1420067273; 256 pages; £49.99, $79.95 Chapman & Hall/CRC;.
- Published in:
- Pharmaceutical Statistics, 2011, v. 10, n. 5, p. 469, doi. 10.1002/pst.425
- By:
- Publication type:
- Article
3
Issues in the assessment of non-inferiority: perspectives drawn from case studies.
- Published in:
- Pharmaceutical Statistics, 2011, v. 10, n. 5, p. 433, doi. 10.1002/pst.512
- By:
- Publication type:
- Article
4
The draft FDA guideline on non-inferiority clinical trials: a critical review from European pharmaceutical industry statisticians.
- Published in:
- Pharmaceutical Statistics, 2011, v. 10, n. 5, p. 414, doi. 10.1002/pst.508
- By:
- Publication type:
- Article
5
Indirect comparisons in the comparative efficacy and non-inferiority settings.
- Published in:
- Pharmaceutical Statistics, 2011, v. 10, n. 5, p. 420, doi. 10.1002/pst.509
- By:
- Publication type:
- Article
6
Bayesian Computation with R, Jim Albert (2008) ISBN 0387-71384-0; 270 pages; $49.95 Springer;.
- Published in:
- Pharmaceutical Statistics, 2011, v. 10, n. 5, p. 471, doi. 10.1002/pst.446
- By:
- Publication type:
- Article
7
10 Years with ICH E10: Choice of Control Groups.
- Published in:
- Pharmaceutical Statistics, 2011, v. 10, n. 5, p. 407, doi. 10.1002/pst.500
- By:
- Publication type:
- Article
8
Designing a non-inferiority study in kidney transplantation: a case study.
- Published in:
- Pharmaceutical Statistics, 2011, v. 10, n. 5, p. 427, doi. 10.1002/pst.511
- By:
- Publication type:
- Article
9
Data and safety monitoring committees in clinical trials, Herson J (2009) ISBN: 9781420070378; 173 pages + xviii; £54.99, $89.95 Chapman and Hall/CRC;.
- Published in:
- Pharmaceutical Statistics, 2011, v. 10, n. 5, p. 467, doi. 10.1002/pst.423
- By:
- Publication type:
- Article
10
Modeling data with structural and temporal correlation using lower level and higher level multilevel models.
- Published in:
- Pharmaceutical Statistics, 2011, v. 10, n. 5, p. 395, doi. 10.1002/pst.479
- By:
- Publication type:
- Article
11
Time to end the non-inferiority complex?
- Published in:
- Pharmaceutical Statistics, 2011, v. 10, n. 5, p. 393, doi. 10.1002/pst.519
- By:
- Publication type:
- Article
12
Introduction to statistical methods for clinical trials, Thomas D Cook, David L DeMets ISBN: 978-1-58488-027-1; 439 pages; $73.95 Chapman and Hall/CRC.
- Published in:
- Pharmaceutical Statistics, 2011, v. 10, n. 5, p. 473, doi. 10.1002/pst.451
- By:
- Publication type:
- Article
13
Determining the non-inferiority margin for patient reported outcomes.
- Published in:
- Pharmaceutical Statistics, 2011, v. 10, n. 5, p. 410, doi. 10.1002/pst.507
- By:
- Publication type:
- Article
14
Active controlled studies in antibiotic drug development.
- Published in:
- Pharmaceutical Statistics, 2011, v. 10, n. 5, p. 454, doi. 10.1002/pst.518
- By:
- Publication type:
- Article
15
Adjusting for covariates in non-inferiority studies with margins defined as risk differences.
- Published in:
- Pharmaceutical Statistics, 2011, v. 10, n. 5, p. 461, doi. 10.1002/pst.520
- By:
- Publication type:
- Article
16
An evidential approach to non-inferiority clinical trials.
- Published in:
- Pharmaceutical Statistics, 2011, v. 10, n. 5, p. 440, doi. 10.1002/pst.513
- By:
- Publication type:
- Article